RecruitingNCT06739330
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Sponsor
Tanta University
Enrollment
150 participants
Start Date
Dec 19, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age ≥ 18 years.
- Both sexes.
- Patients with metabolic dysfunction-associated fatty liver disease (MAFLD).
Exclusion Criteria4
- History of thyroid disease or treatment (e.g., thyroid nodules, thyroid cancer, hypothyroidism, and hyperthyroidism).
- Patients with alcoholic liver disease take more than 40g of alcohol (or four units) per day.
- Viral hepatitis.
- Pregnant women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEFibroscan
Fibroscan will be used to assess the stages of fibrosis and steatosis using Dimensional ultrasound TE (transient elastography). Dimensional ultrasound TE (transient elastography) will be used for staging liver fibrosis and steatosis by measuring the velocity of a low frequency (50 Hz) elastic shear wave propagating through the liver.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06739330